Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
- PMID: 35366961
- PMCID: PMC8971269
- DOI: 10.1016/S1473-3099(22)00207-9
Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
Conflict of interest statement
We declare no competing interests.
Comment on
-
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.Lancet Infect Dis. 2022 Jun;22(6):791-801. doi: 10.1016/S1473-3099(22)00140-2. Epub 2022 Apr 1. Lancet Infect Dis. 2022. PMID: 35366959 Free PMC article.
References
-
- Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. 2022;23:186–193. - PubMed
-
- Cerqueira-Silva T, Andrews JR, Boaventura VS, et al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00140-2. published March 31. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
